Profile | GDS4284 / 1553723_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 294.998 | 56 |
GSM687648 | Patient 402 control | 799.476 | 71 |
GSM687653 | Patient 403 control | 165.776 | 46 |
GSM687658 | Patient 404 control | 510.616 | 64 |
GSM687663 | Patient 411 control | 1128.97 | 76 |
GSM687668 | Patient 422 control | 554.462 | 65 |
GSM687673 | Patient 424 control | 839.019 | 71 |
GSM687678 | Patient 425 control | 729.852 | 68 |
GSM687683 | Patient 427 control | 566.561 | 64 |
GSM687688 | Patient 428 control | 107.393 | 36 |
GSM687695 | Patient 441 control | 3355.97 | 91 |
GSM687699 | Patient 443 control | 1406.12 | 79 |
GSM687704 | Patient 444 control | 550.399 | 65 |
GSM687707 | Patient 448 control | 218.79 | 47 |
GSM687712 | Patient 449 control | 340.041 | 57 |
GSM687719 | Patient 450 control | 1104.92 | 75 |
GSM687724 | Patient 451 control | 306.202 | 55 |
GSM687728 | Patient 452 control | 1663.94 | 82 |
GSM687646 | Patient 401 treated 24h | 203.668 | 48 |
GSM687649 | Patient 402 treated 24h | 952.22 | 73 |
GSM687665 | Patient 411 treated 24h | 828.809 | 71 |
GSM687651 | Patient 402 treated 4 weeks | 928.321 | 73 |
GSM687667 | Patient 411 treated 4 weeks | 777.204 | 70 |
GSM687670 | Patient 422 treated 24h | 327.836 | 56 |
GSM687671 | Patient 422 treated 4 weeks | 536.552 | 64 |
GSM687654 | Patient 403 treated 24h | 257.549 | 54 |
GSM687675 | Patient 424 treated 24h | 780.054 | 70 |
GSM687685 | Patient 427 treated 24h | 765.302 | 70 |
GSM687656 | Patient 403 treated 4 weeks | 220.464 | 52 |
GSM687677 | Patient 424 treated 4 weeks | 379.561 | 59 |
GSM687687 | Patient 427 treated 4 weeks | 486.225 | 63 |
GSM687692 | Patient 428 treated 4h | 421.232 | 61 |
GSM687716 | Patient 449 treated 4h | 230.974 | 52 |
GSM687722 | Patient 450 treated 4h | 601.752 | 66 |
GSM687680 | Patient 425 treated 24h | 500.291 | 63 |
GSM687690 | Patient 428 treated 24h | 289.931 | 56 |
GSM687700 | Patient 443 treated 24h | 1932.87 | 84 |
GSM687705 | Patient 444 treated 24h | 976.031 | 74 |
GSM687714 | Patient 449 treated 24h | 462.287 | 63 |
GSM687721 | Patient 450 treated 24h | 1767.99 | 83 |
GSM687682 | Patient 425 treated 4 weeks | 424.705 | 62 |
GSM687694 | Patient 428 treated 4 weeks | 568.507 | 65 |
GSM687702 | Patient 443 treated 4 weeks | 842.677 | 71 |
GSM687718 | Patient 449 treated 4 weeks | 95.3487 | 33 |
GSM687723 | Patient 450 treated 4 weeks | 611.977 | 66 |
GSM687661 | Patient 404 treated 4h | 307.181 | 55 |
GSM687710 | Patient 448 treated 4h | 239.25 | 52 |
GSM687726 | Patient 451 treated 4h | 241.702 | 49 |
GSM687730 | Patient 452 treated 4h | 48.721 | 11 |
GSM687660 | Patient 404 treated 24h | 6088.3 | 95 |
GSM687697 | Patient 441 treated 24h | 2685 | 88 |
GSM687709 | Patient 448 treated 24h | 290.599 | 54 |
GSM687725 | Patient 451 treated 24h | 343.065 | 56 |
GSM687729 | Patient 452 treated 24h | 5198.55 | 94 |
GSM687727 | Patient 451 treated 4 weeks | 414.63 | 60 |
GSM687731 | Patient 452 treated 4 weeks | 1254.86 | 77 |